Maverick Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$179M Buy
+1,518,805
New +$212M 2.06% 22
2021
Q2
Sell
-1,140
Closed -$222K 816
2021
Q1
$222K Buy
+1,140
New +$234K ﹤0.01% 481

Other funds holding RGEN

Maverick Capital's RGEN Position: Q1 2026 in Review

Maverick Capital opened a new position in Repligen (RGEN) in Q1 2026: 1,518,805 shares worth $179M. The stake represents 2.06% of the portfolio and ranks #22 among its holdings. This is a return to the name: Maverick Capital previously reported a position in RGEN as recently as Q1 2021.

Maverick Capital first reported a position in RGEN in Q1 2021 and has held it in 2 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Maverick Capital held 1,518,805 shares of Repligen worth $179M as of Q1 2026.
  • Repligen was a new Maverick Capital position in Q1 2026.
  • Repligen made up 2.06% of Maverick Capital's portfolio in Q1 2026, its #22 holding.
  • Maverick Capital first reported a position in Repligen in Q1 2021 and has held it in 2 quarters since.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Maverick Capital's 13F filing for Q1 2026, filed 15 May 2026.